WhiteLab Genomics

WhiteLab Genomics is a startup founded in 2019, based in Paris and Boston and leveraging Artificial Intelligence to accelerate and mitigate risks in early-stage R&D within the field of genomic medicine. We’re using biological data guided rational approaches to improve these cell and gene therapies, DNA or RNA-based, addressing both viral and non-viral delivery. We are engaged in partnerships with renowned academic institutions (INSERM, ICM, Institut de la Vision, Genethon), as well as biotech and pharmaceutical companies (Sanofi, SIREN Biotechnology). Our tools and approaches are aimed to address critical challenges in the biopharma industry through accelerating target discovery, vector (either viral and non-viral) and payload design, and bioproduction. By bringing together the power of computer sciences and biology, we help our customers develop more genomic medicines, faster, in leaner ways and make those revolutionary drugs more accessible, affordable, and safer to patients.